ABCB1 and epilepsy: Upregulation of P-glycoprotein has been reported in drug-resistant epilepsy [99] and SE models and is associated with reduced efficacy of ASMs that are substrates for P-glycoprotein, namely levetiracetam, phenytoin, and phenobarbital [100,101].